For Laboratory Research Use Only · Not for Human or Veterinary Use · 21+

Metabolic & Fat Loss Research

Retatrutide

Retatrutide

The triple agonist

$124.0025% OFF · code RESEARCH25
Third-Party TestedCOA Every VialUSA Shipped

What It Is

A triple agonist targeting GIP, GLP-1, and glucagon receptors — studied for combined incretin and glucagon signaling on energy expenditure and substrate use.

How It Works

Retatrutide reference art
GIP-R / GLP-1R
Studied for combined incretin signaling on glucose handling and appetite pathways.
Glucagon-R
Investigated for hepatic fat-oxidation and energy-expenditure signaling.

What the Research Shows

2023 · NEJM · Phase 2 (Jastreboff et al.)
Investigated body-weight endpoints in a research setting.

Citations reference published research. For research purposes only; no therapeutic claims.

Research Focus

  • ✓Studied for triple-pathway metabolic modeling
  • ✓Investigated for energy-expenditure research

Blends Well With

Tirzepatide
$109.00
Semaglutide
$100.00
NAD+
$54.00

Frequently Asked Questions

What is Retatrutide?
A triple GIP/GLP-1/glucagon receptor agonist studied in metabolic research.
What receptors does it target?
GIPR, GLP-1R, and the glucagon receptor.
Is it FDA approved?
No — sold for research use only, not for human use.
Shop Retatrutide · 25% off →

Code RESEARCH25 · applied at checkout

For research use only. Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease. Not evaluated by the FDA. 21+. US shipping only. Charge appears as GULFPORT LOGIS.
© 2026 Choice Peptide Labs